RBX7455 Before Surgery for the Treatment of Operable Breast Cancer
Status:
Recruiting
Trial end date:
2025-12-17
Target enrollment:
Participant gender:
Summary
This clinical trial studies the side effects and possible benefits of RBX7455 given before
surgery in treating patients with breast cancer that can be removed by surgery (operable).
RBX7455 contains live intestinal microbes (active drug), which are obtained from healthy
human stool and may restore the normal balance of microorganisms in the intestines through
the transplant of live and beneficial microorganisms.